Organization
InMed Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
InMed Pharmaceuticals, Inc.
... CSE: INOTCQB: IMLFF InMed Pharmaceuticals, Inc.("InMed" or the "Company") (CSE:IN; OTCQB: IMLFF), a biopharmaceutical company specializing in ...
... all clinical and regulatory work. Though currently valued at only US$81 million, InMed's capabilities position it among the ranks of larger biotechs with important innovations ...
... InMed Pharmaceuticals, Inc.("InMed" or the "Company") (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing ...
... CSE: INOTCQB: IMLFF InMed Pharmaceuticals, Inc.("InMed" or the "Company") (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing ...
... CSE: IN OTCQB: IMLFF InMed Pharmaceuticals Inc.("InMed" or the "Company") (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing ...
... CSE: IN OTCQB: IMLFF InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the ...
... CSE: INOTCQB: IMLFF InMed Pharmaceuticals, Inc.("InMed" or the "Company") (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing ...
... InMed Pharmaceuticals, Inc.("InMed" or the "Company") (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing ...
... Three and Six Months Ended December 31, 2016 A Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases; ...
... CSE: IN OTCQB: IMLFF InMed Pharmaceuticals, Inc.("InMed" or the "Company") (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing ...
... Three and Six Months Ended December 31, 2016 A Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases; ...
... CSE: INOTCQB: IMLFF InMed Pharmaceuticals, Inc.("InMed" or the "Company") (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing ...
... Three and Six Months Ended December 31, 2016 A Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases; ...
... Three and Six Months Ended December 31, 2016 A Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases; ...
... One Lithium, continues significant downtrend, decreases 1.7%on high volume 17:00 EDT [-1.7%] InMed Pharmaceuticals continues significant downtrend; drops 3.6% Its MCap is CAD16.2 million (US$13 ...
... Three and Six Months Ended December 31, 2016 A Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases; ...
... Three and Six Months Ended December 31, 2016 A Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases; ...
... Three and Six Months Ended December 31, 2016 A Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases; ...
... Three and Six Months Ended December 31, 2016 A Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases; ...
... Three and Six Months Ended December 31, 2016 A Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases; ...
... Three and Six Months Ended December 31, 2016 A Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases; ...
... Three and Six Months Ended December 31, 2016 A Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases; ...
... CSE: INOTCQB: IMLFF InMed Pharmaceuticals, Inc.("InMed" or the "Company") (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤